Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | TP53 |
Variant | E349fs |
Impact List | frameshift |
Protein Effect | unknown |
Gene Variant Descriptions | TP53 E349fs results in a change in the amino acid sequence of the Tp53 protein beginning at aa 349 of 393, likely resulting in premature truncation of the functional protein (UniProt.org). E349fs has been identified in sequencing studies (PMID: 24140581, PMID: 36741442), but has not been biochemically characterized and therefore, its effect on Tp53 protein function is unknown (PubMed, Jan 2024). |
Associated Drug Resistance | |
Category Variants Paths |
TP53 mutant TP53 exon10 TP53 E349fs |
Transcript | NM_000546.6 |
gDNA | chr17:g.(7670664_7670665) |
cDNA | c.(1045_1044) |
Protein | p.E349fs |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_001407266.1 | chr17:g.(7670664_7670665) | c.(1045_1044) | p.E349fs | RefSeq | GRCh38/hg38 |
NM_001276761.1 | chr17:g.(7669629_7669630) | c.(1045_1044) | p.E349fs | RefSeq | GRCh38/hg38 |
NM_000546.6 | chr17:g.(7670664_7670665) | c.(1045_1044) | p.E349fs | RefSeq | GRCh38/hg38 |
NM_000546 | chr17:g.(7670664_7670665) | c.(1045_1044) | p.E349fs | RefSeq | GRCh38/hg38 |
NM_001126118.1 | chr17:g.(7669629_7669630) | c.(1045_1044) | p.E349fs | RefSeq | GRCh38/hg38 |
NM_001276761.3 | chr17:g.(7669629_7669630) | c.(1045_1044) | p.E349fs | RefSeq | GRCh38/hg38 |
NM_001407265.1 | chr17:g.(7669629_7669630) | c.(1045_1044) | p.E349fs | RefSeq | GRCh38/hg38 |
NM_001126118 | chr17:g.(7669629_7669630) | c.(1045_1044) | p.E349fs | RefSeq | GRCh38/hg38 |
NM_000546.5 | chr17:g.(7670664_7670665) | c.(1045_1044) | p.E349fs | RefSeq | GRCh38/hg38 |
NM_001276761 | chr17:g.(7669629_7669630) | c.(1045_1044) | p.E349fs | RefSeq | GRCh38/hg38 |
NM_001126112.2 | chr17:g.(7670664_7670665) | c.(1045_1044) | p.E349fs | RefSeq | GRCh38/hg38 |
NM_001276760.1 | chr17:g.(7669629_7669630) | c.(1045_1044) | p.E349fs | RefSeq | GRCh38/hg38 |
NM_001276760 | chr17:g.(7669629_7669630) | c.(1045_1044) | p.E349fs | RefSeq | GRCh38/hg38 |
NM_001276760.3 | chr17:g.(7669629_7669630) | c.(1045_1044) | p.E349fs | RefSeq | GRCh38/hg38 |
NM_001126112.3 | chr17:g.(7670664_7670665) | c.(1045_1044) | p.E349fs | RefSeq | GRCh38/hg38 |
NM_001407264.1 | chr17:g.(7670664_7670665) | c.(1045_1044) | p.E349fs | RefSeq | GRCh38/hg38 |
NM_001126118.2 | chr17:g.(7669629_7669630) | c.(1045_1044) | p.E349fs | RefSeq | GRCh38/hg38 |
NM_001407262.1 | chr17:g.(7670664_7670665) | c.(1045_1044) | p.E349fs | RefSeq | GRCh38/hg38 |
NM_001407263.1 | chr17:g.(7669629_7669630) | c.(1045_1044) | p.E349fs | RefSeq | GRCh38/hg38 |
NM_001407267.1 | chr17:g.(7669629_7669630) | c.(1045_1044) | p.E349fs | RefSeq | GRCh38/hg38 |
NM_001126112 | chr17:g.(7670664_7670665) | c.(1045_1044) | p.E349fs | RefSeq | GRCh38/hg38 |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|